QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SynthesisChina Warehouse
What is Orlistat?
Orlistat is an irreversible pancreatic lipase inhibitor — covalently binds the serine active site of gastric and pancreatic lipases, blocking dietary triglyceride hydrolysis and fat absorption (~30% reduction). Research tool for lipase enzymology, fat malabsorption models, and intestinal lipid metabolism research. Research use only.
Research Applications
Lipase Inhibition Enzymology
Pancreatic/gastric lipase covalent inhibition kinetics, Ki, selectivity profiling
Fat Absorption Models
Intestinal TG hydrolysis blockade, fecal fat excretion, dietary fat handling
Obesity Research
Weight management pharmacology, adiposity reduction, lipid malabsorption models
GI Physiology
Intestinal lipid sensing, CCK release, gut hormone response to unabsorbed fat
Lipase SAR Studies
Orlistat scaffold for structure-activity relationship of lipase inhibitors
Quick Specs
| Form | Raw bulk powder (crystalline/amorphous) |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 96829-58-2 |
| Molecular Formula | C₂₉H₅₃NO₅, MW 495.7 |
| Identity | MS molecular weight confirmed — every batch |
| Compound Type | Pancreatic Lipase Inhibitor / Anti-Obesity Agent |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months (unopened) |
